PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

Carlo Pirazzi, Luca Valenti, Benedetta Maria Motta, Piero Pingitore, Kristina Hedfalk, Rosellina Margherita Mancina, Maria Antonella Burza, Cesare Indiveri, Yvelise Ferro, Tiziana Montalcini, Cristina Maglio, Paola Dongiovanni, Silvia Fargion, Raffaela Rametta, Arturo Pujia, Linda Andersson, Saswati Ghosal, Malin Levin, Olov Wiklund, Michelina Iacovino & 2 others Jan Borén, Stefano Romeo

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Retinoids are micronutrients that are stored as retinyl esters in the retina and hepatic stellate cells (HSCs). HSCs are key players in fibrogenesis in chronic liver diseases. The enzyme responsible for hydrolysis and release of retinyl esters from HSCs is unknown and the relationship between retinoid metabolism and liver disease remains unclear. We hypothesize that the patatin-like phospholipase domain-containing 3 (PNPLA3) protein is involved in retinol metabolism in HSCs. We tested our hypothesis both in primary human HSCs and in a human cohort of subjects with non-alcoholic fatty liver disease (N 5 146). Here we show that PNPLA3 is highly expressed in human HSCs. Its expression is regulated by retinol availability and insulin, and increased PNPLA3 expression results in reducedlipid droplet content. PNPLA3 promotes extracellular release of retinol from HSCs in response to insulin. We also show that purified wild-type PNPLA3 hydrolyzes retinyl palmitate into retinol and palmitic acid. Conversely, this enzymatic activity is markedly reduced with purified PNPLA3 148M, a common mutation robustly associated with liver fibrosis and hepatocellular carcinoma development. We also find the PNPLA3 I148M genotype to be an independent (P 5 0.009 in a multivariate analysis) determinant of circulating retinolbinding protein 4, a reliable proxy for retinol levels in humans. This study identifies PNPLA3 as a lipase responsible for retinyl-palmitate hydrolysis in HSCs in humans. Importantly, this indicates a potential novel link between HSCs, retinoid metabolism and PNPLA3 in determining the susceptibility to chronic liver disease.

Original languageEnglish
Article numberddu121
Pages (from-to)4077-4085
Number of pages9
JournalHuman Molecular Genetics
Volume23
Issue number15
DOIs
Publication statusPublished - 2014

Fingerprint

Hepatic Stellate Cells
Phospholipases
Lipase
Human Activities
Vitamin A
Retinoids
Liver Diseases
Esters
Hydrolysis
Chronic Disease
Insulin
retinol palmitate
Palmitic Acid
Micronutrients
Proxy
Liver Cirrhosis
Retina
Hepatocellular Carcinoma
Proteins
Multivariate Analysis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology
  • Medicine(all)

Cite this

Pirazzi, C., Valenti, L., Motta, B. M., Pingitore, P., Hedfalk, K., Mancina, R. M., ... Romeo, S. (2014). PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Human Molecular Genetics, 23(15), 4077-4085. [ddu121]. https://doi.org/10.1093/hmg/ddu121

PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. / Pirazzi, Carlo; Valenti, Luca; Motta, Benedetta Maria; Pingitore, Piero; Hedfalk, Kristina; Mancina, Rosellina Margherita; Burza, Maria Antonella; Indiveri, Cesare; Ferro, Yvelise; Montalcini, Tiziana; Maglio, Cristina; Dongiovanni, Paola; Fargion, Silvia; Rametta, Raffaela; Pujia, Arturo; Andersson, Linda; Ghosal, Saswati; Levin, Malin; Wiklund, Olov; Iacovino, Michelina; Borén, Jan; Romeo, Stefano.

In: Human Molecular Genetics, Vol. 23, No. 15, ddu121, 2014, p. 4077-4085.

Research output: Contribution to journalArticle

Pirazzi, C, Valenti, L, Motta, BM, Pingitore, P, Hedfalk, K, Mancina, RM, Burza, MA, Indiveri, C, Ferro, Y, Montalcini, T, Maglio, C, Dongiovanni, P, Fargion, S, Rametta, R, Pujia, A, Andersson, L, Ghosal, S, Levin, M, Wiklund, O, Iacovino, M, Borén, J & Romeo, S 2014, 'PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells', Human Molecular Genetics, vol. 23, no. 15, ddu121, pp. 4077-4085. https://doi.org/10.1093/hmg/ddu121
Pirazzi C, Valenti L, Motta BM, Pingitore P, Hedfalk K, Mancina RM et al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. Human Molecular Genetics. 2014;23(15):4077-4085. ddu121. https://doi.org/10.1093/hmg/ddu121
Pirazzi, Carlo ; Valenti, Luca ; Motta, Benedetta Maria ; Pingitore, Piero ; Hedfalk, Kristina ; Mancina, Rosellina Margherita ; Burza, Maria Antonella ; Indiveri, Cesare ; Ferro, Yvelise ; Montalcini, Tiziana ; Maglio, Cristina ; Dongiovanni, Paola ; Fargion, Silvia ; Rametta, Raffaela ; Pujia, Arturo ; Andersson, Linda ; Ghosal, Saswati ; Levin, Malin ; Wiklund, Olov ; Iacovino, Michelina ; Borén, Jan ; Romeo, Stefano. / PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells. In: Human Molecular Genetics. 2014 ; Vol. 23, No. 15. pp. 4077-4085.
@article{9e5e0800f0b54d41a292cb6502fa9702,
title = "PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells",
abstract = "Retinoids are micronutrients that are stored as retinyl esters in the retina and hepatic stellate cells (HSCs). HSCs are key players in fibrogenesis in chronic liver diseases. The enzyme responsible for hydrolysis and release of retinyl esters from HSCs is unknown and the relationship between retinoid metabolism and liver disease remains unclear. We hypothesize that the patatin-like phospholipase domain-containing 3 (PNPLA3) protein is involved in retinol metabolism in HSCs. We tested our hypothesis both in primary human HSCs and in a human cohort of subjects with non-alcoholic fatty liver disease (N 5 146). Here we show that PNPLA3 is highly expressed in human HSCs. Its expression is regulated by retinol availability and insulin, and increased PNPLA3 expression results in reducedlipid droplet content. PNPLA3 promotes extracellular release of retinol from HSCs in response to insulin. We also show that purified wild-type PNPLA3 hydrolyzes retinyl palmitate into retinol and palmitic acid. Conversely, this enzymatic activity is markedly reduced with purified PNPLA3 148M, a common mutation robustly associated with liver fibrosis and hepatocellular carcinoma development. We also find the PNPLA3 I148M genotype to be an independent (P 5 0.009 in a multivariate analysis) determinant of circulating retinolbinding protein 4, a reliable proxy for retinol levels in humans. This study identifies PNPLA3 as a lipase responsible for retinyl-palmitate hydrolysis in HSCs in humans. Importantly, this indicates a potential novel link between HSCs, retinoid metabolism and PNPLA3 in determining the susceptibility to chronic liver disease.",
author = "Carlo Pirazzi and Luca Valenti and Motta, {Benedetta Maria} and Piero Pingitore and Kristina Hedfalk and Mancina, {Rosellina Margherita} and Burza, {Maria Antonella} and Cesare Indiveri and Yvelise Ferro and Tiziana Montalcini and Cristina Maglio and Paola Dongiovanni and Silvia Fargion and Raffaela Rametta and Arturo Pujia and Linda Andersson and Saswati Ghosal and Malin Levin and Olov Wiklund and Michelina Iacovino and Jan Bor{\'e}n and Stefano Romeo",
year = "2014",
doi = "10.1093/hmg/ddu121",
language = "English",
volume = "23",
pages = "4077--4085",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "15",

}

TY - JOUR

T1 - PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

AU - Pirazzi, Carlo

AU - Valenti, Luca

AU - Motta, Benedetta Maria

AU - Pingitore, Piero

AU - Hedfalk, Kristina

AU - Mancina, Rosellina Margherita

AU - Burza, Maria Antonella

AU - Indiveri, Cesare

AU - Ferro, Yvelise

AU - Montalcini, Tiziana

AU - Maglio, Cristina

AU - Dongiovanni, Paola

AU - Fargion, Silvia

AU - Rametta, Raffaela

AU - Pujia, Arturo

AU - Andersson, Linda

AU - Ghosal, Saswati

AU - Levin, Malin

AU - Wiklund, Olov

AU - Iacovino, Michelina

AU - Borén, Jan

AU - Romeo, Stefano

PY - 2014

Y1 - 2014

N2 - Retinoids are micronutrients that are stored as retinyl esters in the retina and hepatic stellate cells (HSCs). HSCs are key players in fibrogenesis in chronic liver diseases. The enzyme responsible for hydrolysis and release of retinyl esters from HSCs is unknown and the relationship between retinoid metabolism and liver disease remains unclear. We hypothesize that the patatin-like phospholipase domain-containing 3 (PNPLA3) protein is involved in retinol metabolism in HSCs. We tested our hypothesis both in primary human HSCs and in a human cohort of subjects with non-alcoholic fatty liver disease (N 5 146). Here we show that PNPLA3 is highly expressed in human HSCs. Its expression is regulated by retinol availability and insulin, and increased PNPLA3 expression results in reducedlipid droplet content. PNPLA3 promotes extracellular release of retinol from HSCs in response to insulin. We also show that purified wild-type PNPLA3 hydrolyzes retinyl palmitate into retinol and palmitic acid. Conversely, this enzymatic activity is markedly reduced with purified PNPLA3 148M, a common mutation robustly associated with liver fibrosis and hepatocellular carcinoma development. We also find the PNPLA3 I148M genotype to be an independent (P 5 0.009 in a multivariate analysis) determinant of circulating retinolbinding protein 4, a reliable proxy for retinol levels in humans. This study identifies PNPLA3 as a lipase responsible for retinyl-palmitate hydrolysis in HSCs in humans. Importantly, this indicates a potential novel link between HSCs, retinoid metabolism and PNPLA3 in determining the susceptibility to chronic liver disease.

AB - Retinoids are micronutrients that are stored as retinyl esters in the retina and hepatic stellate cells (HSCs). HSCs are key players in fibrogenesis in chronic liver diseases. The enzyme responsible for hydrolysis and release of retinyl esters from HSCs is unknown and the relationship between retinoid metabolism and liver disease remains unclear. We hypothesize that the patatin-like phospholipase domain-containing 3 (PNPLA3) protein is involved in retinol metabolism in HSCs. We tested our hypothesis both in primary human HSCs and in a human cohort of subjects with non-alcoholic fatty liver disease (N 5 146). Here we show that PNPLA3 is highly expressed in human HSCs. Its expression is regulated by retinol availability and insulin, and increased PNPLA3 expression results in reducedlipid droplet content. PNPLA3 promotes extracellular release of retinol from HSCs in response to insulin. We also show that purified wild-type PNPLA3 hydrolyzes retinyl palmitate into retinol and palmitic acid. Conversely, this enzymatic activity is markedly reduced with purified PNPLA3 148M, a common mutation robustly associated with liver fibrosis and hepatocellular carcinoma development. We also find the PNPLA3 I148M genotype to be an independent (P 5 0.009 in a multivariate analysis) determinant of circulating retinolbinding protein 4, a reliable proxy for retinol levels in humans. This study identifies PNPLA3 as a lipase responsible for retinyl-palmitate hydrolysis in HSCs in humans. Importantly, this indicates a potential novel link between HSCs, retinoid metabolism and PNPLA3 in determining the susceptibility to chronic liver disease.

UR - http://www.scopus.com/inward/record.url?scp=84903996547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903996547&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddu121

DO - 10.1093/hmg/ddu121

M3 - Article

VL - 23

SP - 4077

EP - 4085

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 15

M1 - ddu121

ER -